ISRG 인튜이티브 서지컬 · Intuitive Surgical, Inc.

매출 +20% 성장.

종가$428.12
시가총액$1,507억
업종헬스케어
다음 실적 발표2026-10-20
PER51.0배
매출 성장(최근 4분기)+20%
영업이익률28%
애널리스트 순상향률0.0%
목표가 상승여력+12%
공매도 거래 비중54%
유명 투자자 보유3곳
1년 수익률-6.6%

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-po

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목